#United States #New York #Rowley Law #HilleVax #XOMA

Rowley Law PLLC Investigates HilleVax Acquisition

On August 5, 2025, Rowley Law PLLC announced its investigation into possible securities law violations concerning HilleVax, Inc. (NASDAQ: HLVX) and its board of directors. This probe comes in light of the proposed acquisition by XOMA Royalty Corporation (NASDAQ: XOMA). According to the transaction details, shareholders of HilleVax are set to receive $1.95 in cash along with one contingent value right for each share they own. The acquisition is scheduled to be finalized in September 2025.

Background of the Investigation

The legal firm, Rowley Law PLLC, is focusing on the acquisition's implications for shareholders, as they may be affected by various legal aspects surrounding the deal. The investigation is aimed at ensuring that HilleVax’s board of directors are acting in the shareholders’ best interests and are compliant with existing securities regulations. If violations are identified, shareholders could have grounds for legal action to protect their investments.

How Shareholders Can Get Involved

Shareholders of HilleVax, Inc. interested in this ongoing investigation can find more information on Rowley Law’s website. They can also reach out directly to Shane Rowley, Esq., who is leading the case, at Rowley Law PLLC's office in White Plains, New York. The firm's dedicated contact number is provided for shareholders who wish to discuss their concerns or obtain further clarification about the investigation.

Importance of Corporate Governance

This investigation underscores the critical role of corporate governance and transparency in publicly-traded companies. As mergers and acquisitions often come with risks and complexities, ensuring due diligence is essential not only for the companies involved but also for maintaining investor confidence in the market.

Rowley Law PLLC's Role

Rowley Law PLLC specializes in representing shareholders nationwide in various legal matters, including class actions and derivative lawsuits related to corporate governance. The firm has a track record of advocating for shareholders' rights and ensuring that companies adhere to the law.

Conclusion

As the acquisition of HilleVax, Inc. by XOMA Royalty Corporation moves forward, the scrutiny from Rowley Law PLLC highlights the importance of protecting shareholder interests during significant corporate changes. Shareholders are encouraged to remain informed and actively participate in discussions regarding the legal implications of this acquisition. With the transaction expected to close this September, the outcome of this investigation could pave the way for future corporate governance practices in similar scenarios.